Physician profile
Danielle Olla
NPI 1619497773
$4,371.20
in general payments reported to CMS, 2019-2025
14 companies · $368 in 2025
The $368 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $752 · 2020: $53.35 · 2022: $1,757 · 2023: $494 · 2024: $947 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,809.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wardlow Enterprises | $1,585.00 | 2019-2022 | |
| Rti Surgical, INC | $487.87 | 2023-2025 | |
| Kerecis Limited | $461.48 | 2022 | |
| Abbvie INC. | $409.58 | 2024 | |
| Mentor Worldwide LLC | $386.94 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $220.75 | 2019-2022 | |
| Axogen | $156.98 | 2024 | Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Integra Lifesciences Corporation | $146.32 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Sanara Medtech INC. | $144.00 | 2025 | Celleraterx |
| Avita Medical Americas, LLC | $138.65 | 2023 | Recell |
| Tepha INC | $82.10 | 2019 | |
| Depuy Synthes Sales INC. | $71.50 | 2020-2023 | Trumatch |
| Endo Pharmaceuticals INC. | $65.05 | 2019-2023 | Xiaflex |
| Baudax Bio INC. | $14.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Olla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.